BRCAGeneECOGScoreWomen ages40+ shouldhave a clinicalbreast examat least yearlyMetastasisLapatinibAntiemeticSERMFamilyHistoryCDK4/6InhibitorsMastodyniaGailModelSelf-examinationDoseDenseTherapyHormoneReceptorStatusLCISPI3KinaseInhibitorsPathologicResponseApoptosisAntibodyTherapyBilateralProphylacticMastectomyCMFChemotherapyCytotoxicGeneticPredispositionCo-survivorRaloxifeneGeneMutationLumpKappaEpsilonIn-situCarcinomaGeneticCounselingTyrosine-KinaseInhibitorDocetaxelBOCA5-FluorouracilHER-2TumorGradeAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PhyllodesTumorAxillarySamplingRADLymphoscintigraphyOvarianSuppressionER+BevacizumabDown-StagingIntraductalPapillomaPalpationGuaranteedRenewableInsuranceBreastCancerDefinitiveSurgery1 in 8womenBreastTomosynthesisChemotherapyDimplingGermlineMutationRelapseMethotrexateProgestinCyclophosphamideFlowCytometryMultifocalTumorsMastectomymTORInhibitorsGenomicTestingMRIAdvocacyCheckpointInhibitorMorpheaMultimodalityTherapyCapecitabineTamoxifenBiopsyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AyurvedaEstradiolEstrogenHerceptinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EGFRLumpectomyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriple +/-BreastCancerAbsoluteRiskMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersER-StagingCystDoxorubicinOligometastasesPalbociclibCAMKi-67RateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCachexiaPagetDiseasePARPInhibitorsAromataseInhibitorsMegestrolAcetateCalcificationsBI-RADSRadiotherapyAdenocarcinomaAnastrozoleNeoadjuvantTherapyPaclitaxelFISHChemopreventionAngiogenesisCytostaticLymphNodeStatusAdjuvantTherapyImmunotherapyBrachytherapyACChemotherapyAlopeciaFibroadenomaPrecisionMedicineHormoneReplacementTherapyBRCAGeneECOGScoreWomen ages40+ shouldhave a clinicalbreast examat least yearlyMetastasisLapatinibAntiemeticSERMFamilyHistoryCDK4/6InhibitorsMastodyniaGailModelSelf-examinationDoseDenseTherapyHormoneReceptorStatusLCISPI3KinaseInhibitorsPathologicResponseApoptosisAntibodyTherapyBilateralProphylacticMastectomyCMFChemotherapyCytotoxicGeneticPredispositionCo-survivorRaloxifeneGeneMutationLumpKappaEpsilonIn-situCarcinomaGeneticCounselingTyrosine-KinaseInhibitorDocetaxelBOCA5-FluorouracilHER-2TumorGradeAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.PhyllodesTumorAxillarySamplingRADLymphoscintigraphyOvarianSuppressionER+BevacizumabDown-StagingIntraductalPapillomaPalpationGuaranteedRenewableInsuranceBreastCancerDefinitiveSurgery1 in 8womenBreastTomosynthesisChemotherapyDimplingGermlineMutationRelapseMethotrexateProgestinCyclophosphamideFlowCytometryMultifocalTumorsMastectomymTORInhibitorsGenomicTestingMRIAdvocacyCheckpointInhibitorMorpheaMultimodalityTherapyCapecitabineTamoxifenBiopsyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.AyurvedaEstradiolEstrogenHerceptinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55EGFRLumpectomyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriple +/-BreastCancerAbsoluteRiskMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltPhysicalactivity mayreduce therisk of breastcancersER-StagingCystDoxorubicinOligometastasesPalbociclibCAMKi-67RateEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearCachexiaPagetDiseasePARPInhibitorsAromataseInhibitorsMegestrolAcetateCalcificationsBI-RADSRadiotherapyAdenocarcinomaAnastrozoleNeoadjuvantTherapyPaclitaxelFISHChemopreventionAngiogenesisCytostaticLymphNodeStatusAdjuvantTherapyImmunotherapyBrachytherapyACChemotherapyAlopeciaFibroadenomaPrecisionMedicineHormoneReplacementTherapy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
  1. BRCA Gene
  2. ECOG Score
  3. Women ages 40+ should have a clinical breast exam at least yearly
  4. Metastasis
  5. Lapatinib
  6. Antiemetic
  7. SERM
  8. Family History
  9. CDK4/6 Inhibitors
  10. Mastodynia
  11. Gail Model
  12. Self-examination
  13. Dose Dense Therapy
  14. Hormone Receptor Status
  15. LCIS
  16. PI3 Kinase Inhibitors
  17. Pathologic Response
  18. Apoptosis
  19. Antibody Therapy
  20. Bilateral Prophylactic Mastectomy
  21. CMF Chemotherapy
  22. Cytotoxic
  23. Genetic Predisposition
  24. Co-survivor
  25. Raloxifene
  26. Gene Mutation
  27. Lump
  28. Kappa Epsilon
  29. In-situ Carcinoma
  30. Genetic Counseling
  31. Tyrosine-Kinase Inhibitor
  32. Docetaxel
  33. BOCA
  34. 5-Fluorouracil
  35. HER-2
  36. Tumor Grade
  37. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  38. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  39. Phyllodes Tumor
  40. Axillary Sampling
  41. RAD
  42. Lymphoscintigraphy
  43. Ovarian Suppression
  44. ER+
  45. Bevacizumab
  46. Down-Staging
  47. Intraductal Papilloma
  48. Palpation
  49. Guaranteed Renewable Insurance
  50. Breast Cancer
  51. Definitive Surgery
  52. 1 in 8 women
  53. Breast Tomosynthesis
  54. Chemotherapy
  55. Dimpling
  56. Germline Mutation
  57. Relapse
  58. Methotrexate
  59. Progestin
  60. Cyclophosphamide
  61. Flow Cytometry
  62. Multifocal Tumors
  63. Mastectomy
  64. mTOR Inhibitors
  65. Genomic Testing
  66. MRI
  67. Advocacy
  68. Checkpoint Inhibitor
  69. Morphea
  70. Multimodality Therapy
  71. Capecitabine
  72. Tamoxifen
  73. Biopsy
  74. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  75. Ayurveda
  76. Estradiol
  77. Estrogen
  78. Herceptin
  79. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  80. EGFR
  81. Lumpectomy
  82. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  83. Triple +/- Breast Cancer
  84. Absolute Risk
  85. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  86. Physical activity may reduce the risk of breast cancers
  87. ER-
  88. Staging
  89. Cyst
  90. Doxorubicin
  91. Oligometastases
  92. Palbociclib
  93. CAM
  94. Ki-67 Rate
  95. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  96. Cachexia
  97. Paget Disease
  98. PARP Inhibitors
  99. Aromatase Inhibitors
  100. Megestrol Acetate
  101. Calcifications
  102. BI-RADS
  103. Radiotherapy
  104. Adenocarcinoma
  105. Anastrozole
  106. Neoadjuvant Therapy
  107. Paclitaxel
  108. FISH
  109. Chemoprevention
  110. Angiogenesis
  111. Cytostatic
  112. Lymph Node Status
  113. Adjuvant Therapy
  114. Immunotherapy
  115. Brachytherapy
  116. AC Chemotherapy
  117. Alopecia
  118. Fibroadenoma
  119. Precision Medicine
  120. Hormone Replacement Therapy